Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Data on the efficacy of antipsychotics as monotherapy for obsessive-compulsive disorder (OCD) are inadequate. This report presents the case of a patient with OCD that was successfully treated with risperidone as monotherapy. Assessments revealed significant reductions in OCD symptoms after risperidone treatment (4 mg/d). This report suggests the beneficial effect of risperidone for a patient with OCD comorbid with schizoaffective disorder.


Journal article


Clinical Neuropharmacology

Publication Date





risperidone, obsessive compulsive disorder